Xenon Pharmaceuticals Inc (XENE)
Net Income Growth
-30.73%
Quarterly · Period ending:
XENE Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.73%period ending
Latest reported-30.73%period ending
XENE Quarterly Net Income YoY % (547.58% → -30.73%)
Year-over-year change
High-resolution chart · PNG
XENE net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -30.7298% | |
| -57.274% | |
| -60.2512% | |
| -44.7619% | |
| -46.2364% | |
| -35.7097% | |
| -46.8051% | |
| -29.5654% | |
| -22.0455% | |
| -14.8681% | |
| -19.6497% | |
| -30.4495% | |
| -52.3236% | |
| -112.1352% | |
| -46.2799% | |
| -140.5309% | |
| -40.929% | |
| -24.778% | |
| -107.4495% | |
| -74.4212% | |
| -12,533.7143% | |
| -110.636% | |
| -8.3245% | |
| 0.1804% | |
| 98.2512% | |
| 34.0093% | |
| -32.9283% | |
| 38.323% | |
| -28.2784% | |
| -202.024% | |
| -6.1128% | |
| -85.7789% | |
| -5.7046% | |
| 50.0466% | |
| -34.3271% | |
| -0.363% | |
| -22.6729% | |
| -130.3708% | |
| -52.5019% | |
| -101.5678% | |
| -615.0685% | |
| 22.7692% | |
| -421.6503% | |
| -141.6386% | |
| -5.0407% | |
| -407.7203% | |
| -51.3126% | |
| 44.1047% | |
| 276.4211% | |
| 547.5789% |